Dapiglutide for Obesity - A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

被引：0
|
作者：
Nielsen, Casper Kjaesgaard
Palsson, Thorir
Jensen, Benjamin
Johansen, Nicklas
Pedersen, Miriam
Forman, Julie
Lund, Asger
Knop, Filip Krag
机构：
来源：
OBESITY | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-320
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [21] Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
    Koblan, Kenneth S.
    Hopkins, Seth C.
    Sarma, Kaushik
    Jin, Fengbin
    Goldman, Robert
    Kollins, Scott H.
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (12) : 2745 - 2752
  • [22] Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
    Kenneth S Koblan
    Seth C Hopkins
    Kaushik Sarma
    Fengbin Jin
    Robert Goldman
    Scott H Kollins
    Antony Loebel
    Neuropsychopharmacology, 2015, 40 : 2745 - 2752
  • [23] A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial
    Mathew, Sanjay J.
    Vythilingam, Meena
    Murrough, James W.
    Zarate, Carlos A., Jr.
    Feder, Adriana
    Luckenbaugh, David A.
    Kinkead, Becky
    Parides, Michael K.
    Trist, David G.
    Bani, Massimo S.
    Bettica, Paolo U.
    Ratti, Emiliangelo M.
    Charney, Dennis S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (03) : 221 - 229
  • [24] Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial
    Domany, Yoav
    Shelton, Richard C.
    McCullumsmith, Cheryl B.
    DEPRESSION AND ANXIETY, 2020, 37 (03) : 224 - 233
  • [25] The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial
    Abdallah, Mahmoud S.
    Alarfaj, Sumaiah J.
    Saif, Dalia S.
    El-Naggar, Mostafa E.
    Elsokary, Mohamed A.
    Elsawah, Hozaifa K.
    Zaki, Shimaa Abdelsattar
    Wahsh, Engy A.
    Mansour, Hend E. Abo
    Mosalam, Esraa M.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [26] Multicenter Double-Blind, Proof-of-Concept, Randomized Placebo-Controlled Trial of Riociguat in Systemic Sclerosis-associated Digital Ulcers
    Nagaraja, Vivek
    Spino, Cathie
    Tsou, Pei-Suen
    Domsic, Robyn
    Lafyatis, Robert
    Frech, Tracy
    Gordon, Jessica
    Steen, Virginia
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Efficacy of the Plasma Cluster® device in mild to moderate asthmatic children: A randomized, double-blind, placebo-controlled, proof-of-concept trial
    Inoue, Takashi
    Akashi, Kenichi
    Fujita, Retsu
    Kimura, Ayako
    Watanabe, Masako
    Ida, Hiroyuki
    Ohashi, Yasuo
    Katsunuma, Toshio
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [28] Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study
    Andersen, Anne Sofie Schott
    Maarbjerg, Stine
    Noory, Navid
    Heinskou, Tone Bruvik
    Forman, Julie Lyng
    Cruccu, Giorgio
    Ashina, Messoud
    Bendtsen, Lars
    LANCET NEUROLOGY, 2022, 21 (11): : 994 - 1003
  • [29] Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
    Montgomery, Stuart A.
    Mansuy, Lucilla
    Ruth, Adam
    Bose, Anjana
    Li, Hua
    Li, Dayong
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : 363 - 369
  • [30] Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
    Calabrese, Joseph R.
    Ketter, Terence A.
    Youakim, James M.
    Tiller, Jane M.
    Yang, Ronghua
    Frye, Mark A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (10) : 1363 - 1370
12345